Small-scale randomized controlled trials (RCTs), designed to assess other outcomes, generally report no effect of testosterone administration on CRP [13–15] or WBC [16], although one RCT among hypogonadal men with metabolic syndrome found testosterone decreased CRP [16]. The gene discussed is CRP; the disease is metabolic syndrome.